IDO1 and neoplasm: Controversially, kynurenine signaling through the AhR has been reported to promote the expression of the activating receptors NKp30, NKp46, perforin, and granzyme B in NK cells (108), which is supported by the observation that IDO1 inhibition impairs NK cell activity against tumor cells (109).